Incorrect. CU6, which I have a parcel of, is doing ok and looks promising. CU6 trials are shorter and the payback potential is closer and more visible.
But it is correct that in general the spec biotech sector is getting hammered. No light at the end of the tunnel just yet. We need interest rates to stop rising for this sector to turn.
Incorrect. CU6, which I have a parcel of, is doing ok and looks...
-
- There are more pages in this discussion • 1,391 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.005(1.37%) |
Mkt cap ! $537.4M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 37.0¢ | 35.5¢ | $459.4K | 1.254M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 63364 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 133642 | 8 |
View Market Depth
| Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |